Jonas Feilchenfeldt

Endurance Training in Humans Leads to Fiber Type-Specific Increases in Levels of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 and Peroxisome Proliferator-Activated Receptor-α in Skeletal Muscle

Aaron P. Russell, Jonas Feilchenfeldt, Sylvia Schreiber et al. · Diabetes · 2003 · 448 citations · Full text

Life Sciences, Biochemistry, Physiology +16

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Dieter Koeberle, Jean‐François Dufour, Gyula Demeter et al. · Annals of Oncology · 2016 · 139 citations · Full text

Medicine, Oncology, Pharmacology +15

Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine

Ghassan K. Abou‐Alfa, Paul B. Chapman, Jonas Feilchenfeldt et al. · American Journal of Clinical Oncology · 2010 · 110 citations

Medicine, Immunology, Oncology +17

Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARγ-coactivator 1 (PGC-1)

Jonas Feilchenfeldt, Marie‐Anne Bründler, Claudio Soravia et al. · Cancer Letters · 2003 · 98 citations

Medicine, Molecular Biology, Oncology +11

Expression of Galectin-3 in Normal and Malignant Thyroid Tissue by Quantitative PCR and Immunohistochemistry

Jonas Feilchenfeldt, Martin Tötsch, Sien‐Yi Sheu et al. · Modern Pathology · 2003 · 63 citations · Full text

Medicine, Endocrinology, Pathology +12